back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-09-18 13:05 Tx date 2022-09-16 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+50,000 vol $0.04 each |
5,016,835 | |
| Filed 2022-09-18 13:05 Tx date 2022-09-15 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+50,000 vol $0.04 each |
4,966,835 | |
| Filed 2022-08-04 14:35 Tx date 2022-08-03 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+400,000 vol $0.025 each |
4,916,835 | |
| Filed 2022-03-19 17:18 Tx date 2022-03-18 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,220
+111,000 vol $0.02 each |
7,975,419 | |
| Filed 2022-03-04 16:05 Tx date 2022-02-28 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,365
+91,000 vol $0.015 each |
7,864,419 | |
| Filed 2021-08-06 18:11 Tx date 2021-08-04 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,980
+949,000 vol $0.02 each |
4,516,835 | |
| Filed 2021-07-25 17:11 Tx date 2021-07-21 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+15,000 vol $0.02 each |
3,567,835 | |
| Filed 2021-07-25 17:10 Tx date 2021-07-20 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$720.00
+36,000 vol $0.02 each |
3,552,835 | |
| Filed 2021-05-02 20:53 Tx date 2021-05-02 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
$75,841
+1,516,835 vol $0.05 each |
3,516,835 | |
| Filed 2021-05-02 20:50 Tx date 2021-05-02 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+21,000 vol |
7,773,419 | |
| Filed 2021-03-06 20:28 Tx date 2021-03-06 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1080359 BC LTD (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+200,000 vol |
200,000 | |
| Filed 2021-03-06 20:25 Tx date 2019-02-19 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1080359 BC LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-05 08:15 Tx date 2021-02-02 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,500
+500,000 vol $0.035 each |
2,000,000 | |
| Filed 2021-01-24 12:27 Tx date 2021-01-22 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,370
+79,000 vol $0.03 each |
1,500,000 | |
| Filed 2021-01-22 15:34 Tx date 2021-01-21 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,300
+610,000 vol $0.03 each |
1,421,000 | |
| Filed 2021-01-22 15:33 Tx date 2021-01-20 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,330
+311,000 vol $0.03 each |
811,000 | |
| Filed 2020-11-19 06:44 Tx date 2020-11-16 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,260
+113,000 vol $0.02 each |
500,000 | |
| Filed 2020-11-19 06:43 Tx date 2020-11-12 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+387,000 vol $0.02 each |
387,000 | |
| Filed 2020-11-19 06:41 Tx date 2019-02-19 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Holder: 1175218 BC LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-31 05:44 Tx date 2020-10-23 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,250
+250,000 vol $0.025 each |
7,752,419 | |
| Filed 2020-10-04 16:08 Tx date 2020-10-02 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$240.00
+12,000 vol $0.02 each |
7,502,419 | |
| Filed 2020-08-27 12:37 Tx date 2020-08-26 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,250
+250,000 vol $0.025 each |
7,490,419 | |
| Filed 2020-08-08 07:58 Tx date 2020-08-07 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,625
+75,000 vol $0.035 each |
7,240,419 | |
| Filed 2020-08-06 11:42 Tx date 2020-08-05 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,345
+67,000 vol $0.035 each |
7,165,419 | |
| Filed 2020-08-06 11:41 Tx date 2020-08-04 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$700.00
+20,000 vol $0.035 each |
7,098,419 | |
| Filed 2020-07-30 10:43 Tx date 2020-07-29 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+300,000 vol $0.04 each |
7,078,419 | |
| Filed 2020-07-30 10:43 Tx date 2020-07-28 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+300,000 vol $0.035 each |
6,778,419 | |
| Filed 2020-07-09 06:57 Tx date 2020-07-07 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
6,478,419 | |
| Filed 2020-06-27 10:03 Tx date 2020-06-27 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+900,000 vol $0.05 each |
1,725,000 | |
| Filed 2020-06-27 09:46 Tx date 2020-06-25 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$65,587
+1,311,753 vol $0.05 each |
6,378,419 | |
| Filed 2020-06-26 09:10 Tx date 2020-06-24 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
5,066,666 | |
| Filed 2020-06-18 07:17 Tx date 2020-06-17 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+100,000 vol $0.04 each |
4,966,666 | |
| Filed 2020-06-17 07:43 Tx date 2020-06-12 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+100,000 vol $0.04 each |
4,866,666 | |
| Filed 2020-05-02 09:52 Tx date 2020-05-02 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-83.34
-4,167 vol $0.02 each |
4,766,666 | |
| Filed 2020-05-02 09:30 Tx date 2020-04-30 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135.00
+9,000 vol $0.015 each |
4,770,833 | |
| Filed 2020-05-02 09:28 Tx date 2020-04-28 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+300,000 vol $0.02 each |
4,761,833 | |
| Filed 2019-11-28 13:25 Tx date 2019-04-03 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$49,983
+249,917 vol $0.20 each |
249,917 | |
| Filed 2019-11-28 13:22 Tx date 2019-02-19 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-28 13:18 Tx date 2019-06-15 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,750
+525,000 vol $0.15 each |
825,000 | |
| Filed 2019-11-28 13:17 Tx date 2019-02-19 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-11-06 14:12 Tx date 2019-10-31 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,347
+38,500 vol $0.035 each |
4,461,833 | |
| Filed 2019-08-01 18:24 Tx date 2019-05-27 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+100,000 vol $0.095 each |
4,423,333 | |
| Filed 2019-04-07 20:10 Tx date 2019-04-03 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+500,000 vol $0.15 each |
4,323,333 | |
| Filed 2019-03-15 Tx date 2019-02-19 |
$EAST
EastWest Bioscience Inc. |
Asriel, Ciska
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,823,333 |